Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
OPERATING ACTIVITIES:
Net loss	$ (8,975,862)	$ (2,123,490)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on disposal and impairment of available-for-sale securities		42,821
Loss on derivative liability		$ 350,969
Allowance for inventory obsolescence	$ 18,589
Depreciation	19,955	$ 2,477
Amortization	37,935	31,941
Impairment of intangible assets	65,674
Stock based compensation	5,934,988	341,667
Changes in current assets and liabilities:
Accounts receivable	(53,118)	104,880
Inventory	(97,980)	70,177
Prepaid expenses and other current assets	(5,455)	(11,385)
Accounts payable and accrued expense	177,874	(132,363)
Due from related party	3,819	$ 20,027
Deferred revenue	7,896
Net cash used in operating activities	$ (2,865,685)	$ (1,302,279)
INVESTING ACTIVITIES:
Cash paid on business combination, net		(304,639)
Cash from reverse merger		1,692,896
Cash from sales of available-for-sale securities		$ 168,704
Cash paid on intangible asset acquisition	$ (200,000)
Cash paid on furniture and equipment	(129,227)	$ (27,863)
Net cash (used in) provided by investing activities	(329,227)	1,529,098
FINANCING ACTIVITIES:
Proceeds from common stock issued for cash	3,484,750	$ 653,327
Proceeds from Series G preferred stock issued for cash	$ 1,000,000
Proceeds from warrant exercises		$ 17,000
Proceeds from Series F preferred stock issued for cash		822,750
Redemption of Series B-1 preferred stock		(350,000)
Net cash provided by financing activities	$ 4,484,750	1,143,077
NET (DECREASE) INCREASE IN CASH	1,289,838	$ 1,369,896
CASH, beginning of period	1,369,896
CASH, end of period	2,659,734	$ 1,369,896
Cash paid during the years ended December 31:
Interest	1,904	2,371
Income taxes	159	$ 5,571
Noncash investing and financing activities for the years ended December 31:
Common stock issued for asset acquisition	1,260,000
Conversion of Series A preferred stock to common stock	74	$ 50
Conversion of Series B preferred stock to common stock	1
Conversion of Series B-1 preferred stock to common stock	5
Conversion of Series C preferred stock to common stock	68	$ 2
Conversion of Series D preferred stock to common stock	85
Conversion of Series E preferred stock to common stock	14
Conversion of Series F preferred stock to common stock	3
Conversion of Series G preferred stock to common stock	5
Common stock issued to Series E, F and G holders	$ 25
Cashless exercise of Series E preferred stock attached warrants		$ 1
Derivative liability written off to APIC due to warrant exercise		2,510,793
Reverse merger adjustment		(2,060,518)
Deemed dividend beneficial conversion feature on convertible preferred stock	$ 80,000	192,558
Business combination adjustment		$ 79,000